Literature DB >> 18040636

Pasteurized autograft-prosthesis composite for distal femoral osteosarcoma.

Dae-Geun Jeon1, Min Suk Kim, Wan Hyeong Cho, Won Seok Song, Soo-Yong Lee.   

Abstract

BACKGROUND: We examined the survivorship and functional outcome of the pasteurized autograft-prosthesis composite for distal femoral osteosarcoma. We also evaluated complications including nonunion, loosening, bony resorption, infection, and fracture.
METHODS: We retrospectively reviewed 15 distal femoral osteosarcoma patients who underwent reconstructions using pasteurized autograft-prosthesis composite between 1993 and 2003.
RESULTS: No patient required graft removal during a minimum follow-up of 35 months (average 56 months; range 35-78 months). The average Musculoskeletal Tumor Society System (MTSS) functional score was 86%. Nonunion developed in five patients, and three of them subsequently showed loosening of the stem. No patient experienced infection or fracture.
CONCLUSIONS: Our data suggest that the pasteurized autograft-prosthesis composite could be an easily accessible alternative for the reconstruction of large skeletal defects in the distal femur because of the satisfactory functional outcome with a low rate of ultimate failure and complications in this study.

Entities:  

Mesh:

Year:  2007        PMID: 18040636     DOI: 10.1007/s00776-007-1173-7

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  10 in total

1.  Can bone scintigraphy predict the final outcome of pasteurized autografts?

Authors:  Ahmed Shawky Eid; Dae-Geun Jeon; Wan Hyeong Cho
Journal:  Skeletal Radiol       Date:  2010-02-23       Impact factor: 2.199

2.  Are Pasteurized Autografts Durable for Reconstructions After Bone Tumor Resections?

Authors:  Seung Yong Lee; Dae-Geun Jeon; Wan Hyeong Cho; Won Seok Song; Bum Suk Kim
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

3.  Does Local Zoledronate Applied to Pasteurized Bone Autografts Improve the Likelihood of Union of Graft-Host Junctions after Limb-sparing Surgery?

Authors:  Piya Kiatisevi; Bhasanan Sukanthanak; Pongsiri Piakong; Piyabuth Kittithamvongs
Journal:  Clin Orthop Relat Res       Date:  2022-01-01       Impact factor: 4.755

4.  Alloplastic reconstruction of the extensor mechanism after resection of tibial sarcoma.

Authors:  Boris Michael Holzapfel; Hans Rechl; Stefan Lehner; Hakan Pilge; Hans Gollwitzer; Erwin Steinhauser
Journal:  Sarcoma       Date:  2011-04-11

5.  The healing process of intracorporeally and in situ devitalized distal femur by microwave in a dog model and its mechanical properties in vitro.

Authors:  Zhenwei Ji; Yunlei Ma; Wei Li; Xiaoxiang Li; Guangyi Zhao; Zhe Yun; Jixian Qian; Qingyu Fan
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

6.  Inactivated autograft-prosthesis composite has a role for grade III giant cell tumor of bone around the knee.

Authors:  SongFeng Xu; XiuChun Yu; Ming Xu; ZhiHou Fu
Journal:  BMC Musculoskelet Disord       Date:  2013-11-09       Impact factor: 2.362

7.  Limb function and quality of life after various reconstruction methods according to tumor location following resection of osteosarcoma in distal femur.

Authors:  SongFeng Xu; XiuChun Yu; Ming Xu; ZhiHou Fu; Yu Chen; YuXi Sun; Qing Su
Journal:  BMC Musculoskelet Disord       Date:  2014-12-23       Impact factor: 2.362

8.  Alcohol Devitalization and Replantation for Primary Malignant Bone Tumors of the Knee Joint.

Authors:  Xihai Zhang; Ge Chen; Jun Wang; Lian Tang; Yiran Yin
Journal:  Iran J Public Health       Date:  2017-10       Impact factor: 1.429

9.  Pasteurized Autograft-Prosthesis Composite Reconstruction May Not Be a Viable Primary Procedure for Large Skeletal Defects after Resection of Sarcoma.

Authors:  Seung Yong Lee; Dae-Geun Jeon; Wan Hyeong Cho; Won Seok Song; Chang-Bae Kong; Bum Suk Kim
Journal:  Sarcoma       Date:  2017-06-04

10.  Comparative efficacy of intraoperative extracorporeal irradiated and alcohol-inactivated autograft reimplantation for the management of osteosarcomas-a multicentre retrospective study.

Authors:  Meitao Xu; Ming Xu; Shuai Zhang; Hanqing Li; A I Qiuchi; Xiuchun Yu; Xu Quan Wang
Journal:  World J Surg Oncol       Date:  2021-05-26       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.